Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis. // Pancreatology. – URL: https://www.sciencedirect.com/science/article/pii/S142439032600147X?dgcid=rss_sd_all
Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis. Pancreatology. https://www.sciencedirect.com/science/article/pii/S142439032600147X?dgcid=rss_sd_all
“Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis.” Pancreatology.
@article{article101207,
title = {Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis},
journal = {Pancreatology},
url = {https://www.sciencedirect.com/science/article/pii/S142439032600147X?dgcid=rss_sd_all}
}